Masters Degree Program in Clinical Laboratory Science
Our Master of Science degree program provides students with a broad-based, three semester core curriculum followed by specialized course work and an apprenticeship project. Research is conducted in one of the three following areas: faculty research laboratories, clinical laboratories or the University of New Mexico Medical Laboratory Sciences Program. Research, management or education represent three distinct arms of this professional MS degree program which graduate students may select. The need for advanced degreed personnel in these fields is considerable. Within the University and our clinical affiliate, TriCore Reference Laboratories, you may choose from over 100 research laboratories representing the following specialties:
- Cancer Biology and Epidemiology
- Cell Biology and Physiology
- Development and Stem Cell Biology
- Molecular and Biochemical Basis of Disease
- Molecular Genetics and Genomics
- Toxicology and Pharmacology
- Vascular and Respiratory Biology
- Virology and Microbial Pathogenesis
Introduction: UNM Clinical Laboratory Science Graduate Student Projects in the Department of Pathology
UNM Medical Laboratory Sciences graduate students have access to excellent, concise research projects, sponsored by interested UNM Pathology faculty. Projects are short, discrete and able to be completed during 18 months of the graduate program. Clinical Laboratory Science graduate students receive specific guidance from a research mentor.
Below are descriptions of Clinical Laboratory Science Graduate Student Projects associated with UNM Department of Pathology faculty. For general inquiries about the MLS Program please refer to our Contact Us page.
Both genetic and phenotypic characteristics are assessed in samples from blood cancers. A large fraction of AML cases in New Mexico result in sending samples, two or more per month, for analysis to Tri-Core Reference Labs under the direction of Pathology Department Hematopathologists including Drs. Czuchlewski and Foucar. These samples are prepared for flow cytometric analysis and cytogenetics. The current survival rate in AML has remained at 20%, and there have been no significant new drugs or improvement in survival over several decades. We propose to initiate a collaborative effort between Tri-Core and the University of New Mexico Center for Molecular Discovery to test the sensitivity of patient samples to already approved drugs. These tests would identify drugs and drug combinations suitable for administration to patients failing chemotherapy. The cell sample handling would be optimized to allow phenotypic tests of up to 1000 drugs per 10 million cells. The MLS student participating in this project would gain expertise in cell culture, flow cytometric analysis of blood samples and automation for high throughput screening and drug discovery. Please contact Dr. Larry Sklar for more information on this project, LSklar@salud.unm.edu, 505-272-6892. For general inquiries about the MLS Program please refer to our Contact Us page.
Follow these links to learn more about:
How to apply
Frequently asked questions
UNM Office of Graduate Studies